1. Home
  2. KEQU vs TVGN Comparison

KEQU vs TVGN Comparison

Compare KEQU & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kewaunee Scientific Corporation

KEQU

Kewaunee Scientific Corporation

HOLD

Current Price

$38.72

Market Cap

124.6M

Sector

Industrials

ML Signal

HOLD

Logo Tevogen Bio Holdings Inc.

TVGN

Tevogen Bio Holdings Inc.

HOLD

Current Price

$0.39

Market Cap

89.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
KEQU
TVGN
Founded
1906
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Blank Checks
Sector
Industrials
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
124.6M
89.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
KEQU
TVGN
Price
$38.72
$0.39
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$5.00
AVG Volume (30 Days)
7.4K
1.4M
Earning Date
12-10-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
3.94
N/A
Revenue
$285,515,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$9.72
N/A
Revenue Growth
43.02
N/A
52 Week Low
$30.33
$0.36
52 Week High
$71.33
$1.92

Technical Indicators

Market Signals
Indicator
KEQU
TVGN
Relative Strength Index (RSI) 46.19 39.82
Support Level $37.50 $0.36
Resistance Level $39.53 $0.40
Average True Range (ATR) 1.32 0.03
MACD 0.18 0.00
Stochastic Oscillator 34.44 22.03

Price Performance

Historical Comparison
KEQU
TVGN

About KEQU Kewaunee Scientific Corporation

Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.

About TVGN Tevogen Bio Holdings Inc.

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.

Share on Social Networks: